Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop bile solubility test supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

Bile Solubility Test: Reading Pneumococci and Its Limits

How the bile solubility test works, how it fits with optochin results per the CDC manual, and where subjective reading can mislead.

Written and maintained by CASRAI Editorial Board

Published · Last updated

On this page

Short answer: the bile solubility test checks whether a streptococcal isolate is dissolved by bile salts (sodium deoxycholate). Pneumococci (Streptococcus pneumoniae) lyse, so a clearing tube or a flattened colony counts as a positive result, while bile-resistant streptococci are unaffected. It is rarely read alone: the CDC meningitis laboratory manual pairs it with optochin susceptibility.

General laboratory information only, not medical advice and not a procedure. Follow your laboratory’s validated method and the reagent manufacturer’s instructions.

Definition and scope

Bile solubility is a phenotypic test used on alpha-hemolytic streptococci. Bile salts trigger lysis of pneumococci, so the cell suspension or colony visibly disappears, and the test reads that loss. It identifies a behaviour, not a species name, which is why the sections below spend as much time on what a result does not prove as on what it shows.

The reagents and media used for this kind of work fall under the FDA device category “microorganism differentiation and identification device” in 21 CFR 866.2660: a device intended for medical purposes, made of components such as differential culture media and biochemical reagents, used to differentiate and identify selected microorganisms. The regulation classifies it as Class I (general controls) and exempts it from premarket notification (checked 2026-10-30, Cornell LII copy of the CFR).

How it works in practice

The CDC manual (August 1998 edition; check current laboratory guidance) describes two formats, which differ in how the reagent is applied and read:

Format Reagent named by CDC What counts as positive
Tube 2% deoxycholate (bile salts) added to a saline suspension of the isolate, read against a saline control tube Clearing of the tube or loss of turbidity
Plate (colony spot) A drop of 10% sodium deoxycholate placed directly on a colony Pneumococcal colonies disappear or are flattened; bile-resistant colonies are unaffected

The manual stresses that a freshly prepared plate is essential for the plate format. Because the stated reagent strength differs by format (2% in the tube, 10% for the colony spot), a laboratory should confirm which format its method uses.

Bile solubility next to optochin: a decision aid

The CDC manual places it after optochin susceptibility (a 6 mm disk with 5 µg ethylhydrocupreine) and uses it to settle the middle ground:

Optochin result (CDC manual) Role of bile solubility Conclusion stated by CDC
Zone of 14 mm or more Not needed to call it Pneumococcus
Smaller but definite zone (alpha-hemolytic isolates with zones of 9-13 mm should be tested) Decides the call Bile soluble: pneumococcus. Not bile soluble: not a pneumococcus
No zone Not needed Not a pneumococcus

Esculin hydrolysis is a different test

“Esculin hydrolysis test” is often searched alongside bile solubility, but it is a separate reaction read on separate media. It is covered in the guide to the bile esculin agar test. For where both tests sit among other biochemical steps, see identifying bacteria in the laboratory; for the staining step that usually comes first, see S. pneumoniae Gram stain. Bile salts also appear as a selective ingredient in some media, such as XLD agar, which is a use of deoxycholate unrelated to lysis of pneumococci.

Where it matters for labs and supply decisions

  • Reagent category: deoxycholate reagents and identification media sit under 21 CFR 866.2660 (Class I, 510(k)-exempt), so regulatory status alone does not distinguish one reagent from another.
  • Format drives the reagent: the tube and plate formats use different stated strengths per CDC, so a laboratory sources reagent for the format it validated.
  • Freshness of cultures: the manual requires a freshly prepared plate for the colony spot format.
  • Validation: a peer-reviewed study recommends that each laboratory validate any cut-off against its own verified strains (below).

Common misunderstandings

“A positive result proves S. pneumoniae”

Not on its own. A 2017 Scientific Reports study of 84 isolates found the conventional test generally accurate but difficult to interpret because it rests on subjective human evaluation. In its spectrophotometric version, one S. mitis isolate exceeded the study cut-off, and S. mitis strains with unusually high readings carried the autolysin gene. S. pseudopneumoniae isolates gave intermediate values. The authors describe the data on this as very limited, and the study was small (only 9 S. pseudopneumoniae isolates), so treat it as a caution, not a rule.

“Bile solubility and bile esculin are the same thing”

They are different tests with different readouts; see the esculin section above.

“The test replaces optochin”

In the CDC scheme the two are complementary: optochin first, bile solubility for the borderline zones.

FAQ

What is a positive bile solubility test?

Per the CDC manual, clearing or loss of turbidity in the tube, or colonies that disappear or flatten on the plate, with bile-resistant colonies unaffected. The reading is visual and subjective.

Is esculin hydrolysis part of the bile solubility test?

No. Esculin hydrolysis is a separate test; see the bile esculin agar test guide linked above.

Which reagent is used?

The CDC manual names 2% deoxycholate (bile salts) for the tube format and 10% sodium deoxycholate for the colony spot format.

Sources

  • CDC, Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, 1998 edition, sections on optochin susceptibility and bile solubility: stacks.cdc.gov/view/cdc/28557 (checked 2026-10-30).
  • Slotved HC, Facklam RR, Fuursted K. Sci Rep 2017;7:7167, doi:10.1038/s41598-017-07772-x: PMC5540920 (checked 2026-10-30).
  • 21 CFR 866.2660, microorganism differentiation and identification device: law.cornell.edu/cfr/text/21/866.2660 (checked 2026-10-30).

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Bile Solubility Test: Reading Pneumococci and Its Limits

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →